We have detected a functional interaction between SV40 large T antigen and the mitotic regulator Bub 1. The protein kinase Bub1, a member of the family of checkpoint proteins that monitor the assembly of the mitotic spindle, has been found to be mutated in certain human cancers characterized by aneuploidy. Notably, T antigen can also cause genomic instability by inducing chromosomal aberrations and aneuploidy. T antigen co-immunoprecipitates with endogenous Bub1, as well as with Bub3, another component of the checkpoint complex at the kinetochore. While we have come to think of T antigen as an inactivator of its target proteins as is the case with p53 and pRb, T actually enhances Bub1 kinase activity. Bub1 phosphorylates p53 on ser37, previously identified as a site of phosphorylation by DNA-PK. Genetic analysis demonstrates that interaction of T antigen with Bub1 is not required for immortalization but appears to be necessary for T antigen to deregulate the spindle assembly checkpoint and transform. This interaction with Bub1 suggests a novel role for T antigen, which may provide new insight into its ability to regulate p53, cause chromosome aberrations, and transform. We propose to study the interaction in detail. It is our intent to determine: (1) What are the the mechanistic consequences of Bub1 mediated phosphorylation of p53? (2) Does T antigen direct Bub1 toward other substrates in addition to p53? And (3) Is T antigen's interaction with Bub1 required for T antigen to destabilize the chromosomes in its target cells?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA050661-18
Application #
7223403
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2006-03-01
Budget End
2007-02-28
Support Year
18
Fiscal Year
2006
Total Cost
$280,272
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Becker, Jürgen C; Stang, Andreas; Hausen, Axel Zur et al. (2018) Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC. Cancer Immunol Immunother 67:341-351
Becker, Jürgen C; Stang, Andreas; DeCaprio, James A et al. (2017) Merkel cell carcinoma. Nat Rev Dis Primers 3:17077
Denis, Deborah; Rouleau, Cecile; Schaffhausen, Brian S (2017) A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling. J Virol 91:
Starrett, Gabriel J; Marcelus, Christina; Cantalupo, Paul G et al. (2017) Merkel Cell Polyomavirus Exhibits Dominant Control of the Tumor Genome and Transcriptome in Virus-Associated Merkel Cell Carcinoma. MBio 8:
Cizmecioglu, Onur; Ni, Jing; Xie, Shaozhen et al. (2016) Rac1-mediated membrane raft localization of PI3K/p110? is required for its activation by GPCRs or PTEN loss. Elife 5:
Rouleau, Cecile; Pores Fernando, Arun T; Hwang, Justin H et al. (2016) Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP. J Virol 90:7032-7045
Luo, Leo Y; Kim, Eejung; Cheung, Hiu Wing et al. (2015) The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer. Mol Cancer Res 13:502-9
Hettmer, Simone; Schinzel, Anna C; Tchessalova, Daria et al. (2015) Functional genomic screening reveals asparagine dependence as a metabolic vulnerability in sarcoma. Elife 4:
White, Elizabeth A; Kramer, Rebecca E; Hwang, Justin H et al. (2015) Papillomavirus E7 oncoproteins share functions with polyomavirus small T antigens. J Virol 89:2857-65
Spurgeon, Megan E; Cheng, Jingwei; Bronson, Roderick T et al. (2015) Tumorigenic activity of merkel cell polyomavirus T antigens expressed in the stratified epithelium of mice. Cancer Res 75:1068-79

Showing the most recent 10 out of 147 publications